Evaluation of PCR cycle threshold values by patient population with the quidel lyra SARS-CoV-2 assay

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


The Lyra SARS-CoV-2 assay was the primary method for molecular testing performed at Barnes-Jewish Healthcare System in St. Louis, Missouri during the initial COVID-19 surge from mid-March to late-April 2020. We performed a retrospective analysis of 1,043 positive Lyra SARS-CoV-2 results during these 36 days to investigate associations between cycle threshold (CT) value and patient characteristics. Total RNA were extracted from NP or OP swabs using either the EasyMag or KingFisher automated extraction systems and quantified with RotorGene Q (Qiagen) or Applied Biosystems 7500 Fast Dx thermocyclers respectively. Notably, we found lower a significant median lower CT for samples tested on the KingFisher-ABI 7500 fastDX (KF/ABI) system compared to the EasyMag/RotorGene (EM/RGQ) platform. Since 77.5% of our tests were ran on the EM/RGQ pipeline we then perform additional analysis on these values and found that C T values in outpatient care settings compared to samples obtained in the emergency department or inpatient had significantly lower C T values. These collective findings suggests a difference in viral load amongst various patient populations.

Original languageEnglish
Article number115387
JournalDiagnostic Microbiology and Infectious Disease
Issue number2
StatePublished - Oct 2021


  • Clinical virology
  • Molecular assays
  • SARS-CoV-2


Dive into the research topics of 'Evaluation of PCR cycle threshold values by patient population with the quidel lyra SARS-CoV-2 assay'. Together they form a unique fingerprint.

Cite this